Authors:
Mehta, SR
Yusuf, S
Peters, RJG
Bertrand, ME
Lewis, BS
Natarajan, MK
Maimberg, K
Rupprecht, HJ
Zhao, F
Chrolavicius, S
Copland, I
Fox, KAA
Citation: Sr. Mehta et al., Effects of pretreatment with clopidogrel and aspirin followed by long-termtherapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, LANCET, 358(9281), 2001, pp. 527-533
Authors:
Topol, EJ
Califf, RM
Van de Werf, F
Willerson, JT
Booth, J
White, H
Clayman, M
Deckelbaum, L
Lincoff, AM
Ohman, EM
Bates, E
Gibler, WB
Hochman, J
Kleiman, N
Grinfeld, L
Aylward, P
Armstrong, PW
Heikkila, J
Vahanian, A
Steg, G
Bode, C
Adgy, AAJ
Guetta, V
Ardissino, D
Savonitto, S
Bar, F
Simoons, M
Kontny, F
White, H
Sadowski, Z
Seabra-Gomes, R
Dalby, A
Betriu, A
Swahn, E
Wilcox, R
Frye, RL
Bertrand, ME
DeMets, D
Fox, KKA
Fuster, V
Lee, KL
McCarthy, C
Waller, M
Scherer, J
van de Kerkhove, A
Kukulewicz, L
Booth, JE
Del Valle, M
Hibert, D
Brannon, D
Citation: Ej. Topol et al., Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial, LANCET, 357(9272), 2001, pp. 1905-1914
Authors:
Meurice, T
Bauters, C
Hermant, X
Codron, V
VanBelle, E
Mc Fadden, EP
Lablanche, JM
Bertrand, ME
Amouyel, P
Citation: T. Meurice et al., Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial, LANCET, 357(9265), 2001, pp. 1321-1324
Authors:
Van Belle, E
Ketelers, R
Bauters, C
Perie, M
Abolmaali, K
Richard, F
Lablanche, JM
McFadden, EP
Bertrand, ME
Citation: E. Van Belle et al., Patency of percutaneous transluminal coronary angioplasty sites at 6-monthangiographic follow-up - A key determinant of survival in diabetics after coronary balloon angioplasty, CIRCULATION, 103(9), 2001, pp. 1218-1224
Authors:
Hogan, RE
Bertrand, ME
Deaton, RL
Sommerville, KW
Citation: Re. Hogan et al., Total percentage body weight changes during add-on therapy with tiagabine,carbamazepine and phenytoin, EPILEPSY R, 41(1), 2000, pp. 23-28
Authors:
Bertrand, ME
Simoons, ML
Fox, KAA
Wallentin, LC
Hamm, CW
McFadden, E
De Feyter, PJ
Specchia, G
Ruzyllo, W
Citation: Me. Bertrand et al., Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation - Recommendations of the Task Force of the European Society of Cardiology, EUR HEART J, 21(17), 2000, pp. 1406-1432
Authors:
Boden, WE
van Gilst, WH
Scheldewaert, RG
Starkey, IR
Carlier, MF
Julian, DG
Whitehead, A
Bertrand, ME
Col, JJ
Pedersen, OL
Lie, KI
Santoni, JP
Fox, KM
Citation: We. Boden et al., Diltiazem in acute myocardial infarction treated with thrombolytic agents:a randomised placebo-controlled trial, LANCET, 355(9217), 2000, pp. 1751-1756
Authors:
Bertrand, ME
Rupprecht, HJ
Urban, P
Gershlick, AH
Citation: Me. Bertrand et al., Double-blind study of the safety of clopidogrel with and without a loadingdose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting - The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS), CIRCULATION, 102(6), 2000, pp. 624-629
Authors:
Bauters, C
Amant, C
Boulier, A
Cabrol, P
McFadden, E
Duriez, P
Bertrand, ME
Amouyel, P
Citation: C. Bauters et al., Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin, CIRCULATION, 101(7), 2000, pp. 740-743
Authors:
Bertrand, ME
Esplugas, E
Piessens, J
Rasch, W
Citation: Me. Bertrand et al., Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus anionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty a multicenter, randomized, double-blind study, CIRCULATION, 101(2), 2000, pp. 131-136
Authors:
Vrolix, MCM
Legrand, VM
Reiber, JHC
Grollier, G
Schalij, MJ
Brunel, P
Martinez-Elbal, L
Gomez-Recio, M
Bar, FWHM
Bertrand, ME
Colombo, A
Brachman, J
Citation: Mcm. Vrolix et al., Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial), AM J CARD, 86(4), 2000, pp. 385-389
Authors:
Van Belle, E
Abolmaali, K
Bauters, C
McFadden, EP
Lablanche, JM
Bertrand, ME
Citation: E. Van Belle et al., Restenosis, late vessel occlusion and left ventricular function six monthsafter balloon angioplasty in diabetic patients, J AM COL C, 34(2), 1999, pp. 476-485
Authors:
Le Tourneau, T
Van Belle, E
Corseaux, D
Vallet, B
Lebuffe, G
Dupuis, B
Lablanche, JM
McFadden, E
Bauters, C
Bertrand, ME
Citation: T. Le Tourneau et al., Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: Effects on neointimal hyperplasia and vascular remodeling, J AM COL C, 33(3), 1999, pp. 876-882
Authors:
Verheugt, FWA
Becker, RC
Bertrand, ME
Bode, C
Chesebro, JH
Cleland, JGF
Conti, R
Hillis, WS
Klein, W
Maseri, A
Turpie, AGG
Wallentin, L
Waters, DD
Citation: Fwa. Verheugt et al., Management strategies in unstable coronary artery disease - Current problems and future directions, CLIN CARD, 22(9), 1999, pp. 551-553
Authors:
Bauters, C
Delomez, M
Van Belle, E
McFadden, E
Lablanche, JM
Bertrand, ME
Citation: C. Bauters et al., Angiographically documented late reocclusion after successful coronary angioplasty of an infarct-related lesion is a powerful predictor of long-term mortality, CIRCULATION, 99(17), 1999, pp. 2243-2250
Authors:
Six, I
Van Belle, E
Bordet, R
Corseaux, D
Callebert, J
Dupuis, B
Bauters, C
Bertrand, ME
Citation: I. Six et al., L-Arginine and L-NAME have no effects on the reendothelialization process after arterial balloon injury, CARDIO RES, 43(3), 1999, pp. 731-738
Citation: E. Van Belle et al., Coronary angioplasty in diabetics: Analysis of the problems to improve results., ARCH MAL C, 92(11), 1999, pp. 1637-1645